Issue 29, 2019, Issue in Progress
From the journal:

RSC Advances

Correction: Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer

Changliang Liu,ac   Hongyang Duan,ab   Zijian Zhao,a   Wenzhe Li,ab   Lilusi Ma,a   Xiaocui Fang,*a   Chen Wang*ac  and  Yanlian Yang*ac  

* Corresponding authors

a CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P. R. China
E-mail: fangxc@nanoctr.cn, wangch@nanoctr.cn, yangyl@nanoctr.cn
Tel: +86-10-82545561

b Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, P. R. China

c University of Chinese Academy of Sciences, Beijing 100049, P. R. China

Abstract

Correction for ‘Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer’ by Changliang Liu et al., RSC Adv., 2018, 8, 39948–39956.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C9RA90039J
Article type
Correction
Submitted
16 May 2019
Accepted
16 May 2019
First published
29 May 2019
This article is Open Access
Creative Commons BY license

RSC Adv., 2019,9, 16729-16729

Permissions

Request permissions

Correction: Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer

C. Liu, H. Duan, Z. Zhao, W. Li, L. Ma, X. Fang, C. Wang and Y. Yang, RSC Adv., 2019, 9, 16729 DOI: 10.1039/C9RA90039J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements